Open AccessProfound and sustained response with next-generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvement
Author(s) -
Charlotte Rigaud,
Samuel Abbou,
Stéphane Ducassou,
Mathieu Simonin,
Lou Le Mouël,
Victor Pereira,
Stephanie Gourdon,
Anne Lambilliotte,
Birgit Geoerger,
Véronique MinardColin,
Laurence Brugières
Publication year - 2022
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2021.280081
Subject(s) - anaplastic lymphoma kinase , central nervous system , anaplastic large cell lymphoma , lymphoma , medicine , alk inhibitor , cancer research , oncology , malignant pleural effusion , pleural effusion